ASHLEE MYERS: Open Payments
NPI 1760080766 · PORT ST LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 18 payments from 10 companies in 2025. Trend: 2023 $403 · 2024 $381 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| Amgen Inc. | 3 | $43 |
| Novo Nordisk Inc | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $17 |
Products named: AIRSUPRA, OTEZLA, XIFAXAN, TRELEGY ELLIPTA, Wegovy, CAPLYTA, VYNDAQEL, Ozempic.
Industry payments across FL — which companies pay providers there.
